Navigation Links
New Strategy Eyed for AIDS Treatment
Date:6/22/2009

Discovery of HIV hiding places may pave way for novel therapies

MONDAY, June 22 (HealthDay News) -- A radical new therapy could improve treatment of people with HIV-AIDS by destroying the viruses circulating in the body as well as those hiding in immune system cells, according to a new study.

A team of American and Canadian researchers have high hopes for a combination of targeted chemotherapy and what's known as highly active anti-retroviral (HAART) treatments.

When HIV viruses hide in immune cells, the researchers explained, existing HAART treatments can't reach them. But the study identified where HIV hides in immune cells and the "stealth" mechanisms that enable the virus to elude existing treatments. This finding could lead to new therapies that are different than current treatments, they said.

"Our results argue in favor of a strategy similar to the one used against leukemia, which is targeted chemotherapy, associated with a targeted immune treatment," study co-leader Dr. Rafick-Pierre Sekaly, a professor at the University of Montreal and scientific director of the Vaccine and Gene Therapy Institute of Florida, said in a university news release. "This would make it possible to destroy the cells containing a virus while giving the immune system time to regenerate with healthy cells."

Another co-leader, Dr. Jean-Pierre Routy, an infection and immunity researcher at the Research Institute of the McGill University Health Centre in Montreal, explained the importance of the finding.

"For the first time, this study proves that the HIV reservoirs are not due to a lack of potency of the antiretroviral drugs but to the virus hiding inside two different types of long-life CD4 memory immune cells," Routy said in the news release. "There are several types of HIV reservoirs, each necessitating a different treatment to eliminate them."

The researchers acknowledged, however, that it will take many more years of work before the finding might lead to new treatments for people with HIV-AIDS.

The study appears in the journal Nature Medicine.

More information

The U.S. National Institute of Allergy and Infectious Diseases has more about HIV-AIDS treatment.



-- Robert Preidt



SOURCE: University of Montreal, news release, June 21, 2009


'/>"/>
Copyright©2009 ScoutNews,LLC.
All rights reserved  

Related medicine news :

1. AMDL CEO Featured in CEOCFO Magazine; Details Progress on DR-70 International Commercialization Strategy & Confidence in FY2009 Financial Forecast
2. DURECT Appoints Dr. Joseph Stauffer as Chief Medical Officer and Executive Vice President, Corporate Strategy
3. NIAID media availability: New strategy proposed for designing antibody-based HIV vaccine
4. XELR8 Holdings, Inc. Hires Vice President of Strategy and Network Development
5. Alere Executives Present National Health Improvement Strategy to Congressional and Industry Leaders
6. Diplomat Specialty Pharmacy Promotes Rinku A. Patel, PharmD to Vice President, Pharmacy Strategy
7. MDS Announces Strategy to Focus MDS Pharma Services on Early Stage Operations - Discovery Through Phase IIa
8. Sisters of Charity Health System Appoints Orlando L. Alvarez Jr. to Head Physician Strategy and Business Development
9. Cutler to Direct Debt Management Product Strategy at Ontario Systems
10. American College of Physicians Chooses iPublishCentral to Launch its e-Book Strategy
11. American College of Physicians Chooses iPublishCentral to Launch its e-Book Strategy
Post Your Comments:
*Name:
*Comment:
*Email:
Related Image:
 New Strategy Eyed for AIDS Treatment
(Date:3/24/2017)... ... March 24, 2017 , ... Shamanic healer ... for Shamanic Healing and Spiritual Awakening, proudly presents her Sacred Peru retreat ... This sacred and spiritual journey during the Summer Solstice will also be her ...
(Date:3/24/2017)... (PRWEB) , ... March 24, 2017 , ... ... two panels at the Advanced ERISA Benefit Claims Litigation seminar in Chicago, Illinois. ... the Administrative Record, The majority of cases litigated under ERISA involve claims for ...
(Date:3/24/2017)... ... March 24, 2017 , ... Empower ... upgrading their training and leads programs. , In February, 2017, Empower Brokerage introduced ... agents, Performance Partners is designed to teach how to maximize their sales efforts, ...
(Date:3/24/2017)... ... ... “Vintage and Harvest A Cultivation of Christian Love” is the creation of published author, ... his wife, Anna Marie. He and his wife are the proud parents of four ... of “Shadow and Substance.” , “Love, the agape kind, is seen as more than ...
(Date:3/23/2017)... ... 23, 2017 , ... A recent report from the National Council on Teacher ... NCTQ report suggests, based on a review of GPA and SAT/ACT requirements at 221 ... the U.S. It argues that this higher bar should be set by states, by ...
Breaking Medicine News(10 mins):
(Date:3/24/2017)... , Mar. 24, 2017 Research and Markets has ... Analysis, 2016" report to their offering. ... The IPF pipeline is very strong with a total ... & Co., Inc., Biogen and Sanofi are involved in the development of ... which one is in Phase III stage, 15 are in Phase II ...
(Date:3/24/2017)... Mar 24, 2017 Research and Markets has ... Strategic Business Report" report to their offering. ... The report provides separate comprehensive analytics for the ... Europe , Asia-Pacific , Latin ... provided for the period 2015 through 2022. Also, a six-year historic analysis ...
(Date:3/24/2017)... , March 23, 2017  Provectus Biopharmaceuticals, Inc. ... "Company"), a clinical-stage oncology and dermatology biopharmaceutical company, ... Financing Commitment Term Sheet (the "Definitive Financing") it ... of the Company,s stockholders, who are referred to ... a Form 8-K filed with the Securities and ...
Breaking Medicine Technology: